MLYS Mineralys Therapeutics, Inc. 424B5

MLYS 424B5 filed June 3, 2026

Mineralys Therapeutics, Inc.

This report is being refreshed

An automated blocking check flagged a hard inconsistency in this summary (for example, figures that fail a specific reconciliation), so we've held it back while it's regenerated. That doesn't mean every published report is perfect — only that this one hit a known blocker. Check back shortly, or read the original filing on SEC EDGAR now.

About this filing

Company
Mineralys Therapeutics, Inc. (MLYS)
Form type
424B5
Filed
June 3, 2026
Accession
0001628280-26-040216